272
Participants
Start Date
May 31, 2004
Primary Completion Date
April 30, 2007
Ralfinamide
Oral tablets administered at rising doses of 80 - 320 mg/day
Universitatsklinik Fur Neurologie, Graz
Universitatsklinik Fur Neurologie, Innsbruck
LKH, Klagenfurt
General Hospital AKH, Vienna
Fakultni nemocnice u svate' Anny v Brne, Brno
Fakultni nemocnice Brno, Brno-Bhunice
University Hospital Olomouc, Olomouc
Univercity Hospital Pilsen, Pizen
Fakultni Thomayerova nemocnices poliklinikou, Prague
Na Homolce Hospital, Prague
Neurology Centre, Ahmedabad
M.S. Ramaiah Medical, Bangalore
R.S. R'S Trinity Acute Care Hospital, Chennai
Sri Ramachandra medical College, Chennai
Care Hospital, Hyderabad
Chowpatty Medical Centre, Mumbai
Brain and Mind Institute, Nagpur
Apollo Hospital, Pradesh
Brain Waves Clinic, Pune
Vijaya Health Centre, Vadapalani
Ospedali Riuniti di Bergamo, Bergamo
Ce. S.I. Fondazione Universitaria, Chieti
Ospedale Clinicizzato Universitario SS. Annunziata, Chieti
Arcispedale Sant'Anna, Ferrara
Azienda Ospedaliera San Martino, Genova
Universita degli Studi di Genova, Genova
Ospedale Luigi Sacco, Grassi
Ospedale Civile Umberto I, Mestre
Ospedale San Raffaele, Milan
Istituto Scientifico di Riabilazione di Montescano, Montescano
Policlinico Universitario Federico II, Napoli
UCADH, Pavia
Presidio Ospedaliero Monteluce, Perugia
Universita degli Studi di Roma, Roma
Policlinico G.B. Rossi, Verona
Centrum Medyczne Osteomed, Bialobrzeska
Centrum Kliniczno Badawcze, Elblag
Wojewodzki Szpiyal Spejalistyczny, Gdansk
Center Of Clinical Neurology, Krakow
Osrodek Baden Klinicznych, Lublin
Wojskowy Instytut Medyczny, Warsaw
Wroclaw Medical University, Wroclaw
Oddzial Neurologiczny, Zgierz
Gartnavel General Hospital, Glasgow
Barta and The London NHS Trust, London
Kings College Hospital, London
Solihull Hospital, West Midlands
Lead Sponsor
Newron Pharmaceuticals SPA
INDUSTRY